Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06302920
Other study ID # 0001
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 20, 2024
Est. completion date December 20, 2024

Study information

Verified date March 2024
Source Alanya Alaaddin Keykubat University
Contact Deniz Bulut, A.professor
Phone +90 05059445604
Email denizhava1988@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients will be divided into 2 groups according to the random numbers table, and both groups will receive a conventional physical therapy and rehabilitation program and nutritional support. Afterwards, edema-reducing kinesiotaping will be applied to one group. The applied kinesio tape will remain on the patient for 5 days and will be taped again after 2 days without tape. In this way, taping will be done 3 times in total, once a week for 3 weeks. During this period, patients will continue their routine physical therapy program and measurements will be taken by the same researcher in the 1st week of treatment and 3 weeks later.


Description:

Patients will be divided into 2 groups according to the random numbers table, and both groups will receive a conventional physical therapy and rehabilitation program and nutritional support. Afterwards, edema-reducing kinesiotaping will be applied to one group. The applied kinesio tape will remain on the patient for 5 days and will be taped again after 2 days without tape. In this way, taping will be done 3 times in total, once a week for 3 weeks. During this period, patients will continue their routine physical therapy program and measurements will be taken by the same researcher in the 1st week of treatment and 3 weeks later. Kinesiology tapes have a wavy structure in line with the structure and physiological functions of the skin and have adhesive properties. The adhesive is a heat-activated acrylic. After approximately 20 minutes, the adhesive is fully activated. The tapes are porous, permeable to air and liquid, allow perspiration and dry quickly.Kinesiology tapes have a wavy structure in line with the structure and physiological functions of the skin and have adhesive properties. The adhesive is a heat-activated acrylic. After approximately 20 minutes, the adhesive is fully activated. The tapes are porous, permeable to air and liquid, allow perspiration and dry quickly. The method of application varies depending on the cutting method, application direction and region of the tape. If the anatomy of muscles, joints, ligaments and circulatory system is mastered and the correct techniques appropriate to the situation are used, the chance of success of the technique increases. Lymphatic correction technique is used to reorganize damaged lymphatic circulation. The main goals are to create a dead space in the tissue that allows circulation and to reduce the pressure on the lymph vessels at the tissue level. It directs lymph fluid to larger lymphatic vessels and lymph nodes. This effect can be explained by the elastic qualities and lifting effect of the tape. While lifting the surface skin reduces pressure and ensures lymphatic circulation, the tape provides a massage effect during active movement. Thanks to the tape, maximum contraction and relaxation of the muscles is ensured and the effectiveness of the deeper lymphatic flow is increased. Kinesiophobia (also known as fear of movement); It is defined as an excessive and irrational fear of physical movement to avoid being harmed or injured again. It can also be expressed as an excessive, irrational fear of physical movement and activity resulting from a feeling of vulnerability due to pain. Its prevalence in chronic pain varies between 50-70%. While the existing threatening characteristics of the pain experience may vary depending on the situation and the person, avoidance behavior, which is protective in the short term, paradoxically worsens the problem in the long term. It is stated that kinesiophobia is an important factor in the transition of pain from acute to chronic stages.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 60
Est. completion date December 20, 2024
Est. primary completion date June 20, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: Clinical diagnosis of reflex sympathetic dystrophy Ability to be included in a physical therapy program Exclusion Criteria: Hemiplegia Malignancy Polyacrylamide allergy Open wound in the area to be applied

Study Design


Intervention

Device:
Kinesiotape
Lymphatic correction technique

Locations

Country Name City State
Turkey Alanya Alaaddin Keykubat University Antalya

Sponsors (1)

Lead Sponsor Collaborator
Alanya Alaaddin Keykubat University

Country where clinical trial is conducted

Turkey, 

References & Publications (3)

Çeliker R, Güven Z, Aydog T, et al. Kinezyolojik bantlama teknigi ve uygulama alanlari. Turkiye Fiz Tip ve Rehabil Derg. 2011;57(4):225-235.

Fischer SGL, Zuurmond WWA, Birklein F, Loer SA, Perez RSGM. Anti-inflammatory treatment of Complex Regional Pain Syndrome. Pain. 2010 Nov;151(2):251-256. doi: 10.1016/j.pain.2010.07.020. Epub 2010 Aug 7. No abstract available. — View Citation

Roelofs J, van Breukelen G, Sluiter J, Frings-Dresen MHW, Goossens M, Thibault P, Boersma K, Vlaeyen JWS. Norming of the Tampa Scale for Kinesiophobia across pain diagnoses and various countries. Pain. 2011 May;152(5):1090-1095. doi: 10.1016/j.pain.2011.01.028. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Resting pain The resting pain level of the patients will be measured with the Visual Analogue Scale (VAS).A score between 0 and 10 will be determined by the patient, with 0 being no pain and 10 being the most severe pain level. Beginning, week 3 and week 6
Primary Edema The patients will be physically examined and their wrist circumference and metacarpal circumference will be measured in centimeters. Beginning, week 3 and week 6
Primary Kinesiophobia Kinesiophobia will be assessed using the Tampa Scale for Kinesiophobia. A score above 37 in the test is defined as an indicator of a high level of kinesiophobia. Beginning, week 3 and week 6
See also
  Status Clinical Trial Phase
Completed NCT06100107 - Mirror Therapy in Complex Regional Pain Syndrome Type I N/A
Terminated NCT00006289 - Neurotropin to Treat Chronic Neuropathic Pain Phase 2
Recruiting NCT05877612 - Efficacy of Spinal Cord Stimulation in Burst Mode in the Treatment of Complex Regional Pain Syndromes Type 1 of the Upper Limbs
Terminated NCT03309774 - Complex Regional Pain Syndrome in Children: Impact of Bergès Relaxation on the Autonomic Balance N/A
Completed NCT00625976 - Graded Exposure (GEXP) in Vivo Versus Physiotherapy in Complex Regional Pain Syndrome Type I (CRPS-I) N/A
Recruiting NCT04703647 - Longitudinal Follow-up Study About Complex Regional Pain Syndrome (CRPS) Patients
Completed NCT03377504 - Clinical Evaluation of the Effects of Mirror Therapy in Patients With Complex Regional Pain Syndrome (CRPS) Type 1 N/A
Recruiting NCT06306157 - Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome Phase 4
Recruiting NCT05745025 - rTMS and Rehabilitation for Individuals With CRPS Type 1 N/A
Terminated NCT04667364 - Pain in Complex Regional Pain Syndrome N/A